Quintiles’ First Quarter 2014 Earnings Call Scheduled for Thursday, May 1st


Save Story
Leer en español

Estimated read time: 1-2 minutes

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Apr 9, 2014--Quintiles Transnational Holdings Inc. (NYSE: Q) will release its financial results for the first quarter of 2014 prior to its quarterly earnings call on Thursday, May 1, 2014, at 8:00 a.m. EDT.

The conference call will be accessible, live via webcast, on the Investor Relations section of the Quintiles website at www.quintiles.com/investors. To participate via telephone, please dial +1 (855) 484-7367 in the United States or +1 (631) 259-7541 outside the United States, approximately 15 minutes before the scheduled start of the call.

An archived edition of the conference call will be available online at www.quintiles.com/investors after 1:00 p.m. EDT on Thursday, May 1st.

About Quintiles

Quintiles (NYSE: Q) is the world’s largest provider of biopharmaceutical development and commercial outsourcing services with a network of more than 28,000 employees conducting business in approximately 100 countries. We have helped develop or commercialize all of the top-50 best-selling drugs on the market. Quintiles applies the breadth and depth of our service offerings along with extensive therapeutic, scientific and analytics expertise to help our customers navigate an increasingly complex healthcare environment as they seek to improve efficiency and effectiveness in the delivery of better healthcare outcomes. To learn more about Quintiles, please visit www.quintiles.com.

Click here to subscribe to Mobile Alerts for Quintiles.

CONTACT: Quintiles

Phil Bridges, Media Relations

+ 1-919-998-1653 (office), +1-919-457-6347 (mobile)

phil.bridges@quintiles.com

or

Karl Deonanan, Investor Relations

+1-919-998-2789

InvestorRelations@quintiles.com

KEYWORD: UNITED STATES NORTH AMERICA CANADA NORTH CAROLINA

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL

SOURCE: Quintiles

Copyright Business Wire 2014

PUB: 04/09/2014 08:00 AM/DISC: 04/09/2014 08:00 AM

http://www.businesswire.com/news/home/20140409005069/en

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Most recent Business stories

Related topics

Business
Quintiles

    STAY IN THE KNOW

    Get informative articles and interesting stories delivered to your inbox weekly. Subscribe to the KSL.com Trending 5.
    By subscribing, you acknowledge and agree to KSL.com's Terms of Use and Privacy Policy.

    KSL Weather Forecast